2016
DOI: 10.1016/j.jlumin.2015.08.066
|View full text |Cite
|
Sign up to set email alerts
|

Studying the interaction between trinuclear ruthenium complexes and human serum albumin by means of fluorescence quenching

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
35
0
12

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 57 publications
(47 citation statements)
references
References 41 publications
0
35
0
12
Order By: Relevance
“…[20] In addition to the most commonly investigated use in the solar cells, emerge applications of ruthenium based dyes in other scientific fields, for example, in biomedicine. [1][2][3][4][5][6][7] Ruthenium (II) complexes were shown to bind to DNA defects [7] as well as to be a quantitative DNA detectors. [3] Recently, a number of studies have suggested them as a potential photodynamic agents in the cancer therapy, [4][5][6] live-cell imaging, [21,22] ATP (adenosine-5'-triphosphate) detection, [1] interaction with HSA (human serum albumin), [2] and theranostic applications.…”
Section: Introductionmentioning
confidence: 99%
“…[20] In addition to the most commonly investigated use in the solar cells, emerge applications of ruthenium based dyes in other scientific fields, for example, in biomedicine. [1][2][3][4][5][6][7] Ruthenium (II) complexes were shown to bind to DNA defects [7] as well as to be a quantitative DNA detectors. [3] Recently, a number of studies have suggested them as a potential photodynamic agents in the cancer therapy, [4][5][6] live-cell imaging, [21,22] ATP (adenosine-5'-triphosphate) detection, [1] interaction with HSA (human serum albumin), [2] and theranostic applications.…”
Section: Introductionmentioning
confidence: 99%
“…The strongest ability of quenching is exhibited by Pd [138] and Ru [23,36,52] in binding with albumins and by Cu [44][45][46][47]49,141] in binding with DNA. Minimum quenching constants are observed in binding of albumins with and Pd [150] : pK = 2, and DNA with Ru [151] : pK = 1-2.…”
Section: Discussionmentioning
confidence: 99%
“…The major attention in the case of metal complexes binding with proteins is paid to the therapeutic properties, and only in some cases the binding parameters were studied which, if necessary, were improved by changing temperature [8,23,[33][34][35][36][37][38][39] or selecting organic and inorganic coligands (mostly 1,10-phenantholine and bipyridyl) which bind with a complexing metal together with a drug molecule. [8,24,36,37,[39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54] The complexes under study are mainly biligand complexes containing a drug ligand and coligand. The Figure 3 shows the distribution of the studing from the viewpoint of metals studied.…”
Section: Metal Complexesmentioning
confidence: 99%
See 1 more Smart Citation
“…It is known that linear Stern-Volmer plots indicate one type of quenching mechanism as predominant, either static or dynamic [30]. Moreover, in Table 1, the values of Kq at different temperatures were much higher than the limiting diffusion rate constant of biomolecules (k d ≈ 2.0 × 10 10 M −1 ·s −1 ) [31][32][33][34], which revealed static quenching via forming a complex. For a complex formation process, the affinity constant K a of the binding between FDQL and HSA was analyzed by modified Stern-Volmer Equation (2) [35][36][37]:…”
Section: Fluorescence Quenching Mechanismmentioning
confidence: 92%